Table 1 Baseline characteristics of participants randomized to the alternate and daily dosing arms.
Characteristics | Alternate day group (n = 100) | Daily dose Group (n = 100) | Total |
|---|---|---|---|
Age (years) | 49.23 (± 15.71) | 45.33 (± 17.31) | 47.28 (± 16.60) |
Hemoglobin (g/dl) | 6.53 (± 1.89) | 6.68 (± 1.89) | 6.60 (± 1.88) |
Packed cell volume (%) | 21.28 (± 5.16) | 21.65 (± 5.25) | 21.47 (± 5.20) |
Total WBC counts (cells/microL) | 7568 (± 3584.39) | 7478 (± 3138.05) | 7523 (± 3360.45) |
MCV (fL) | 62.29 (± 8.83) | 62.01 (± 8.95) | 62.15 (± 8.87) |
MCH (pg) | 18.89 (± 3.92) | 19.06 (± 3.86) | 18.97 (± 3.88) |
MCHC (%) | 30.03 (± 2.48) | 30.16 (± 2.28) | 30.09(± 2.38) |
RCW (%) | 23.79 (± 4.07) | 23.80 (± 3.97) | 23.80 (± 4.01) |
Platelet counts (cells/microL) | 299,620 (± 142,764.25) | 311,130 (± 130,666.02) | 305,375 (136,626.49) |
Ferritin (ng/ml) | 56.86 (± 192.97) | 70.92 (± 243.82) | 63.89 (± 219.43) |
Reticulocyte count (%) | 0.74 (± 0.50) | 0.78 (± 0.47) | 0.76 (± 0.49) |
ESR (mm/hr) | 27.56 (± 24.14) | 29.59 (± 26.93) | 28.57 (± 25.53) |
Total Bilirubin(mg/dl) | 0.42 (± 0.27) | 0.45 (± 0.34) | 0.44 (± 0.30) |
SGOT (U/L) | 29.07 (± 27.81) | 39.31 (± 122.24) | 34.19 (± 88.57) |
SGPT (U/L) | 20.88 (± 17.80) | 25.02 (± 45.46) | 22.95 (± 34.50) |
Alkaline phosphatase (U/L) | 87.3 (± 26.89) | 97.52 (± 70.22) | 92.41 (± 53.28) |
Total protein (g/dl) | 6.69 (± 0.70) | 6.58 (± 0.66) | 6.63 (± 0.68) |
Serum Albumin (g/dl) | 3.76 (± 0.55) | 3.73 (± 0.53) | 3.75 (± 0.54) |
Urea (mg/dl) | 21.88 (± 12.56) | 20.72 (± 9.97) | 21.30 (± 11.32) |
Serum Creatinine (mg/dl) | 0.70 (± 0.24) | 0.67 (± 0.24) | 0.68 (± 0.24) |
